ResMed Inc (RMD)

Financial leverage ratio

Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
Total assets US$ in thousands 7,566,820 7,141,330 7,222,420 6,872,390 6,814,560 6,905,090 6,740,790 6,751,710 6,713,880 6,676,100 5,177,560 5,095,850 4,905,260 4,734,740 4,729,170 4,728,120 4,585,720 4,572,860 4,620,840 4,587,380
Total stockholders’ equity US$ in thousands 5,546,130 5,253,010 5,195,030 4,864,040 4,629,920 4,481,850 4,250,380 4,129,900 3,932,510 3,738,130 3,432,890 3,360,750 3,278,800 3,145,840 3,026,050 2,885,680 2,709,230 2,864,980 2,678,860 2,497,030
Financial leverage ratio 1.36 1.36 1.39 1.41 1.47 1.54 1.59 1.63 1.71 1.79 1.51 1.52 1.50 1.51 1.56 1.64 1.69 1.60 1.72 1.84

March 31, 2025 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $7,566,820K ÷ $5,546,130K
= 1.36

The analysis of ResMed Inc.'s financial leverage ratio over the observed period indicates a generally stable but gradually declining trend from June 2020 through March 2024, with some fluctuations along the way. The ratio commenced at 1.84 in June 2020 and progressively decreased, reaching approximately 1.36 by December 2024. This downward trend reflects a consistent reduction in the company’s leverage position over time.

Notably, the ratio experienced some oscillations; it decreased from 1.84 in June 2020 to about 1.51 by December 2021, and further declined to approximately 1.39 by September 2024. The lowest recorded figure within this period is 1.36, observed both at the end of 2024 and in the most recent quarter, March 2025.

The overall pattern suggests actions toward deleveraging or prudent financial management, possibly involving debt repayment or a shift towards greater equity financing. The more moderate ratio values indicate an increasing reliance on equity or a reduction in debt levels relative to the company's assets, which potentially results in lower financial risk and improved solvency.

In summary, ResMed Inc.’s financial leverage ratio demonstrates a declining trend over the analyzed timeframe, reflecting a strategic movement towards a less leveraged financial structure, which may signify strengthening financial stability and a focus on reducing financial risk exposure.